NEO - CIK 0001077183
The table below shows NEOGENOMICS INC's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $146.14M | $164.12M | $154.72M | $346.19M | $361.99M | $355.08M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $167.42M | $155.30M | $153.13M | $151.21M | $151.43M | $146.58M |
| Inventory | $29.84M | $28.46M | $34.17M | $29.77M | $24.46M | $23.21M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $373.68M |
| $382.46M |
| $392.55M |
| $573.93M |
| $590.24M |
| $584.20M |
| Property, plant & equipment | $83.66M | $85.47M | $85.46M | $89.60M | $93.04M | $92.16M |
| Goodwill | $524.00M | $524.34M | $524.14M | $522.77M | $522.77M | $522.77M |
| Total assets | $1.35B | $1.37B | $1.39B | $1.60B | $1.64B | $1.64B |
| Accounts payable | $25.90M | $22.61M | $27.49M | $16.21M | $16.51M | $17.19M |
| Total current liabilities | $84.59M | $97.87M | $100.12M | $279.69M | $296.41M | $289.96M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $517.77M | $536.49M | $539.91M | $713.16M | $732.90M | $727.39M |
| Retained earnings | -$450.91M | -$423.93M | -$396.80M | -$351.70M | -$310.46M | -$292.76M |
| Total equity | $828.76M | $838.29M | $854.04M | $888.27M | $908.21M | $915.88M |